ArticleFrontiers in immunology2023

DSP-0509, a systemically available TLR7 agonist, exhibits combination effect with immune checkpoint blockade by activating anti-tumor immune effects.

Yosuke Ota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.